Correction: Highly potent and selective phosphatidylinositol 4-kinase IIIβ inhibitors as broad-spectrum anti-rhinoviral agents
Avinash G. Vishakantegowda, Dasom Hwang, Prashant Chakrasali, Eunhye Jung, Joo-Youn Lee, Jin Soo Shin, Young-Sik Jung
TL;DR
This paper corrects a previously published study on new inhibitors that target a specific enzyme to fight rhinoviruses.
Contribution
The correction addresses errors in the original study on anti-rhinoviral agents targeting phosphatidylinositol 4-kinase IIIβ.
Findings
The correction clarifies data or methodology in the original paper on enzyme inhibitors.
It ensures accuracy in the reported results of anti-rhinoviral agents.
Abstract
Correction for ‘Highly potent and selective phosphatidylinositol 4-kinase IIIβ inhibitors as broad-spectrum anti-rhinoviral agents’ by Avinash G. Vishakantegowda et al., RSC Med. Chem., 2024, 15, 704–719, https://doi.org/10.1039/D3MD00630A.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
- —Ministry of Science and ICT, South Korea10.13039/501100014188
- —Korea Research Institute of Chemical Technology10.13039/501100003704
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCytokine Signaling Pathways and Interactions · Synthesis and biological activity · Synthesis and Characterization of Heterocyclic Compounds